glp-1 long term risks GLP‐1 receptor agonists and muscle strength: What do we know? Is Ozempic a GLP-1 Medication?

The risk increases when GLP-1 drugs are combined with insulin or sulfonylureas, which is why dose adjustments are necessary in combination therapy

Wegovy, known generically as semaglutide, represents a significant advancement in the treatment of obesity and overweight conditions when combined with a reduced-calorie diet and increased physical activity

Executive summary (1)

Rising GLP-1 demand challenges employer health plans With the steady increase in obesity rates, GLP-1 drugs seem like a convenient solution

The increased sensitivity to sweetness and saltiness may be due in part to the fact that these flavors are especially good at giving us that dopamine high, which is depressed by GLP-1s